Holen Sie sich die Stockscreener-App
32.13
3.91%
1.20
Handel nachbörslich:
32.13
Veracyte Inc Aktie (VCYT) Neueste Nachrichten
Veracyte, Inc. $VCYT Stock Holdings Lifted by First Trust Advisors LP - MarketBeat
Veracyte CFO Chambers sells $662k in VCYT stock - Investing.com Nigeria
Panic Selling: Can Veracyte Inc. ride the EV waveWeekly Trade Analysis & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
Veracyte at Leerink Global Healthcare: Strategic Growth Focus By Investing.com - Investing.com Canada
Are Veracyte's (VCYT) Strong 2025 Profits and Reaffirmed 2026 Outlook Redefining Its Growth Story? - simplywall.st
Insider Sell: Rebecca Chambers Sells Shares of Veracyte Inc (VCY - GuruFocus
Veracyte (NASDAQ:VCYT) CFO Rebecca Chambers Sells 18,341 Shares - MarketBeat
VCYT: Morgan Stanley Lowers Price Target Amidst Underweight Rati - GuruFocus
Morgan Stanley Lowers Price Target on Veracyte to $37 From $48, Keeps Underweight Rating - marketscreener.com
Morgan Stanley cuts Veracyte stock price target on valuation methodology By Investing.com - Investing.com Canada
Morgan Stanley cuts Veracyte stock price target on valuation methodology - Investing.com
Veracyte, Inc. $VCYT Shares Sold by GW&K Investment Management LLC - MarketBeat
Veracyte, Inc. $VCYT Shares Acquired by ARK Investment Management LLC - MarketBeat
Affiliate to sell 6,658 Restricted Stock Units — VCYT (NASDAQ: VCYT) - Stock Titan
[144] VERACYTE, INC. SEC Filing - Stock Titan
Marc Stapley (NASDAQ: VCYT) reports sale of 15,000 shares for $1.92M - Stock Titan
Veracyte (NASDAQ: VCYT) VP has 3,006 shares withheld for taxes - Stock Titan
Veracyte (VCYT) CFO reports 7,234-share tax withholding, not a sale - Stock Titan
[Form 4] VERACYTE, INC. Insider Trading Activity - Stock Titan
Veracyte (VCYT) exec sells 13,425 shares, 117,346 remain - Stock Titan
Veracyte (VCYT) CEO has 19,455 shares withheld to cover taxes - Stock Titan
Segall Bryant & Hamill LLC Has $18.31 Million Stock Holdings in Veracyte, Inc. $VCYT - MarketBeat
Champlain Investment Partners LLC Makes New $40.06 Million Investment in Veracyte, Inc. $VCYT - MarketBeat
VCYT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Veracyte, Inc. (VCYT) Stock Analysis: Uncovering A Promising 34.96% Upside For Investors - DirectorsTalk Interviews
William Blair Investment Management LLC Buys New Stake in Veracyte, Inc. $VCYT - MarketBeat
Veracyte (VCYT) Valuation Check After Strong 2025 Earnings And Reaffirmed 2026 Growth Outlook - Yahoo Finance
JPMorgan Chase & Co. Has $17.81 Million Position in Veracyte, Inc. $VCYT - MarketBeat
Veracyte to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
Cathie Wood’s ARK sells Veracyte stock, buys MercadoLibre - Investing.com South Africa
Cathie Wood’s ARK sells Veracyte stock, buys MercadoLibre By Investing.com - Investing.com Nigeria
Veracyte Inc. Signals Durable Growth in Earnings Call - TipRanks
Veracyte, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:VCYT) 2026-03-02 - Seeking Alpha
Veracyte (VCYT) CCO John Leite receives PSU shares, withholds stock for taxes - Stock Titan
Veracyte (VCYT) CEO reports PSU vesting and tax withholding share disposition - Stock Titan
Veracyte (VCYT) CFO granted shares as PSUs vest, with tax shares withheld - Stock Titan
Veracyte (NASDAQ: VCYT) officer gets PSU vesting, withholds shares - Stock Titan
Veracyte (VCYT) SVP awarded 50,999 shares; some withheld for taxes - Stock Titan
How Veracyte’s Profit Jump and 2026 Outlook Will Impact Veracyte (VCYT) Investors - simplywall.st
Vanguard Group Inc. Raises Stock Holdings in Veracyte, Inc. $VCYT - MarketBeat
Veracyte, Inc. (NASDAQ:VCYT) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Veracyte Stock Soars 8.48%, Hits Intraday High of $39.89 - Markets Mojo
Veracyte (VCYT) Margin Expansion To 12.8% Tests Bullish Profitability Narratives - simplywall.st
Veracyte, Inc. (NASDAQ:VCYT) Q4 2025 Earnings Call Transcript - Insider Monkey
Decoding Veracyte Inc (VCYT): A Strategic SWOT Insight - GuruFocus
Artisan Partners Limited Partnership Acquires 1,048,692 Shares of Veracyte, Inc. $VCYT - MarketBeat
VCYT Gains Analyst Support: Needham Raises Price Target | VCYT S - GuruFocus
Veracyte Presents 15 Studies on Decipher Cancer Tests at ASCO GU Symposium - Clinical Lab Products
Veracyte Q4 Earnings Beat Estimates, Revenues Grow Y/Y, Stock Rises - Yahoo Finance
Veracyte (NASDAQ:VCYT) Shares Gap Up on Analyst Upgrade - MarketBeat
Veracyte (NASDAQ:VCYT) Price Target Raised to $48.00 - MarketBeat
Veracyte stock price target raised to $48 by Needham on growth - Investing.com Australia
Veracyte’s ASCO Urology Data And TrueMRD Launch Test Investor Patience - simplywall.st
Veracyte, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Veracyte Q4 Earnings Call Highlights - MarketBeat
Veracyte Announces Fourth Quarter and Full Year 2025 Financial Results - BioSpace
Veracyte Inc earnings beat by $0.14, revenue topped estimates - Investing.com India
Veracyte Inc (VCYT) Q4 2025 Earnings Call Highlights: Strong Rev - GuruFocus
0.34%
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):